Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 94 | SFEBES2023 | Next issue

Society for Endocrinology BES 2023

Glasgow, UK
13 Nov 2023 - 15 Nov 2023

Card image cap
SfE BES is the UK's leading endocrinology meeting. It will return to Glasgow in 2023.

How Do I…? Sessions

How do I…? 2

Previous section
How do I…? 1
Table of contents

ea0094hdi2.1 | How do I…? 2 | SFEBES2023

Abstract Unavailable...
0 shares

ea0094hdi2.2 | How do I…? 2 | SFEBES2023

Abstract Unavailable...
0 shares

ea0094hdi2.3 | How do I…? 2 | SFEBES2023

Abstract Unavailable...
0 shares

ea0094hdi2.4 | How do I…? 2 | SFEBES2023

How do I\..use anabolic bone therapy in my management of osteoporosis?

Walsh Jennie

Teriparatide (PTH 1-34) is licensed for treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures and treatment of corticosteroid-induced osteoporosis. It is administered as a daily subcutaneous injection for two years. It is used in patients with severe osteoporosis who have not responded to, or not been able to tolerate bisphosphonate treatment. It is contraindicated in hypercalcaemia, bone cancer, bone radiotherapy and Paget’s disease....
0 shares

ea0094hdi2.5 | How do I…? 2 | SFEBES2023

Abstract Unavailable...
0 shares

ea0094hdi2.6 | How do I…? 2 | SFEBES2023

Abstract Unavailable...
0 shares

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more